Accueil>>Signaling Pathways>> Antibody-drug Conjugate/ADC Related>> ADC Linker>>Aminooxy-PEG2-alcohol

Aminooxy-PEG2-alcohol

Catalog No.GC66811

L'aminooxy-PEG2-alcool est un lieur PEG ADC non clivable à 2 unités utilisé dans la synthèse de conjugués anticorps-médicament (ADC). L'aminooxy-PEG2-alcool est également un lieur PROTAC à base de PEG qui peut être utilisé dans la synthèse des PROTAC.

Products are for research use only. Not for human use. We do not sell to patients.

Aminooxy-PEG2-alcohol Chemical Structure

Cas No.: 185022-12-2

Taille Prix Stock Qté
100mg
956,00 $US
En stock
250mg
1 492,00 $US
En stock
500mg
2 297,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Aminooxy-PEG2-alcohol is a non-cleavable 2 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs)[1]. Aminooxy-PEG2-alcohol is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs[2].

ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker[1].
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[2].

[1]. Marek Kwiatkowski. Conjugates of biologically active molecules to functionalized polymers. WO2013186632A2.
[2]. Murray BS, et al. Reactive thermoresponsive copolymer scaffolds. Chem Commun (Camb). 2010 Dec 7;46(45):8651-3.

Avis

Review for Aminooxy-PEG2-alcohol

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Aminooxy-PEG2-alcohol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.